Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer

BACKGROUND: The aims of this study were to investigate the link between enhancer of zeste homolog 2 (EZH2) and histone deacetylase (HDAC) in preclinical studies and in human lung cancer tissue microarrays. METHODS: Enhancer of zeste homolog 2 and HDAC1 mRNA expression in two lung adenocarcinoma (LUA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Shi, Bin, Behrens, Carmen, Vaghani, Viralkumar, Riquelme, Erick Marcelo, Rodriguez‐Canales, Jaime, Kadara, Humam, Lin, Heather, Lee, Jack, Liu, Hui, Wistuba, Ignacio, Simon, George
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Cancer Biology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797579/
https://ncbi.nlm.nih.gov/pubmed/31456359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1855
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky